Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a respiratory illness with systemic immune cell activation, inflammation, widespread multiorgan dysfunction, and thrombosis.

Opportunities in the COVID-19 tests market include developing innovative products, leveraging global and regional trends, understanding competitive dynamics, and accessing country-specific regulatory ...

Peer-Reviewed Article Describes Clinical and Immunologic Rationale for Dual-Antigen MVA-Based Vaccine Designed to Address Limitations of First-Generation COVID-19 Vaccines in Highly Vulnerable ...

The first known meta-analysis of how SARS-CoV-2 variant type and time since infection influence long-COVID symptoms ties Omicron to brain fog and paresthesia (numbness and tingling), while earlier ...

Aghinagh G.A.A. Lotto Results No Jackpot winner. Numbers Drawn 4, 23, 32. Jackpot €1,150. €50 Rose O’Connor, Lyroe. €20 Tina Keating, Coolnadane; €20 James Griffin c/o Donal Callaghan; €20 Marian ...

Researchers from St Petersburg University and other scientific organizations have developed a method to identify inhibitors of the enzyme responsible for coronavirus replication. While investigating ...

Once Upon a Farm, PBC (NYSE: OFRM) (or the "Company"), a leading high-growth company driving systemic improvement in childhood nutrition, today announced financial results for the fourth quarter and ...

SEATTLE, WA, UNITED STATES, March 12, 2026 /EINPresswire.com/ — International Long COVID Awareness Day is observed each year on March 15th. There is an urgent need for prevention, research, funding, ...

On March 1, 2026, the "Residential Real Estate Rule" issued by the US Department of the Treasury's Financial Crimes Enforcement Network (FinCEN) went into effect. The rule requires the filing of a ...

The introduction of highly effective direct-acting antivirals has transformed the HCV treatment landscape, enabling cure ...

High-dose Vitamin D doesn't reduce acute COVID severity but shows a promising signal for reducing Long COVID and brain fog.

The U.S. government and academic labs are pushing multiple universal vaccine candidates through early clinical trials, targeting influenza strains and coronaviruses that mutate faster than today’s ...